Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral T-Cell Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+21 more
Masonic Cancer Center, University of Minnesota 70
Testing effectiveness (Phase 2)Study completedNCT02220985
What this trial is testing

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia of Ambiguous Lineage+20 more
Fred Hutchinson Cancer Center 84
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Testing effectiveness (Phase 2)Looking for participantsNCT05313243
What this trial is testing

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

Who this might be right for
T-Cell Lymphoma
Yale University 32
Early research (Phase 1)Ended earlyNCT02663518
What this trial is testing

A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors

Who this might be right for
Hematologic MalignanciesSolid Tumor
Pfizer 249
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT02732275
What this trial is testing

DS-3201b in Participants With Lymphomas

Who this might be right for
Lymphoma, MalignantNon-hodgkin Lymphoma
Daiichi Sankyo Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT01226472
What this trial is testing

Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001

Who this might be right for
Peripheral T-cell LymphomaCutaneous T-cell Lymphoma
Kyowa Kirin Co., Ltd. 1
Testing effectiveness (Phase 2)Study completedNCT00007345
What this trial is testing

Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma

Who this might be right for
Cutaneous T Cell LymphomaPeripheral T Cell Lymphoma
National Cancer Institute (NCI) 131
Testing effectiveness (Phase 2)Study completedNCT02424045
What this trial is testing

Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma

Who this might be right for
T-cell Lymphoma
Samsung Medical Center 30
Not applicableUnknownNCT05821192
What this trial is testing

Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell Lymphoma
Ou Bai, MD/PHD 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07725705
What this trial is testing

SHR2554 Plus Liposomal Mitoxantrone as First-line Treatment for Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
PTCLFirst Line Treatment
Institute of Hematology & Blood Diseases Hospital, China 44
Testing effectiveness (Phase 2)UnknownNCT05527275
What this trial is testing

A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma

Who this might be right for
Relapsed and Refractory Peripheral T-cell Lymphoma
Sun Yat-sen University 78
Testing effectiveness (Phase 2)UnknownNCT04457830
What this trial is testing

The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).

Who this might be right for
Peripheral T Cell Lymphoma
Shandong New Time Pharmaceutical Co., LTD 105
Very early researchUnknownNCT04696705
What this trial is testing

Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Peripheral T Cell Lymphoma (PTCL)
Institute of Hematology & Blood Diseases Hospital, China 10
Testing effectiveness (Phase 2)Ended earlyNCT05105412
What this trial is testing

Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas

Who this might be right for
Peripheral T-cell Lymphomas (PTCL)
National Health Research Institutes, Taiwan 12
Testing effectiveness (Phase 2)Study completedNCT01716806
What this trial is testing

Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Hodgkin DiseasePeripheral T Cell Lymphoma
Seagen Inc. 131
Very early researchUnknownNCT05208853
What this trial is testing

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma

Who this might be right for
Hodgkin LymphomaNK/T Cell LymphomaPeripheral T Cell Lymphoma, Unspecified+5 more
Zhejiang University 9
Next Page